Comparing two IV nutrition options for children after stem cell transplant
Part of Blood & lymphatic, Cancer clinical trials.
This study compares two types of IV nutrition (Intralipid and SMOF Lipid) for children undergoing stem cell transplants for leukemia. It aims to find which option is better for helping them recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 18 years old or younger.
- They must have a confirmed diagnosis of acute leukemia and be scheduled for a stem cell transplant.
- They need to be able to receive nutrition through an IV (parenteral nutrition).
- No known allergy to eggs or soy protein.
- No severe organ failure or very high bilirubin levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two drugs, ATLG and ATG, to see which one helps rebuild the immune system better after a stem cell transplant for blood cancer. It aims to improve recovery and reduce complications.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This expanded-access study offers a specific type of stem cell transplant preparation that removes certain immune cells (CD3 and CD19) from donor stem cells. It is for children who need a transplant but do not have a fully matched sibling donor and whose team cannot use the hospital’s usual matching device protocol.
This trial tests whether adding dexamethasone, intravenous immunoglobulin, and extra donor cells can lower donor-specific antibodies in people receiving half-matched stem cell transplants. The goal is to help more patients safely get a transplant when fully matched donors aren't available.
This study tests whether giving liquid nutrition through a feeding tube during stem cell transplant is better than the usual diet. The goal is to see if it is safe and can help patients feel better during recovery.
This trial tests if SMOFlipid, a special lipid emulsion given through an IV, is safe for children and adults who need most of their nutrition from IV for at least 8 weeks. It looks for side effects like essential fatty acid deficiency or liver problems.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.